131
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Can Elderly Patients with Peritoneal Metastasis Induced by Appendiceal or Colorectal Tumours Benefit from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

, , , , , , , , & show all
Pages 559-568 | Published online: 30 Mar 2021

References

  • Etzioni DA, Beart RW Jr, Madoff RD, et al. Impact of the aging population on the demand for colorectal procedures. Dis Colon Rectum. 2009;52(4):583–590. doi:10.1007/DCR.0b013e3181a1d18319404056
  • Rasool S, Kadla SA, Rasool V, et al. A comparative overview of general risk factors associated with the incidence of colorectal cancer. Tumour Biol. 2013;34(5):2469–2476. doi:10.1007/s13277-013-0876-y23832537
  • Teo M. Peritoneal-based malignancies and their treatment. Ann Acad Med Singapore. 2010;39(1):54–57.20126816
  • van Gestel YR, de Hingh IH, van Herk-sukel MP, et al. Patterns of metachronous metastases after curative treatment of colorectal cancer. Cancer Epidemiol. 2014;38(4):448–454. doi:10.1016/j.canep.2014.04.00424841870
  • Mo S, Cai G. Multidisciplinary treatment for colorectal peritoneal metastases: review of the literature. Gastroenterol Res Pract. 2016;2016:1516259. doi:10.1155/2016/151625928105045
  • Bushati M, Rovers KP, Sommariva A, et al. The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2018;44(12):1942–1948. doi:10.1016/j.ejso.2018.07.00330075978
  • Cashin PH, Mahteme H, Spång N, et al. Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: a randomised trial. Eur J Cancer. 2016;53:155–162. doi:10.1016/j.ejca.2015.09.01726751236
  • Van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378(3):230–240. doi:10.1056/NEJMoa170861829342393
  • Klaver CEL, Wisselink DD, Punt CJA, et al. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. Lancet Gastroenterol Hepatol. 2019;4(10):761–770. doi:10.1016/S2468-1253(19)30239-031371228
  • Chua TC, Yan TD, Saxena A, Morris DL. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg. 2009;249(6):900–907. doi:10.1097/SLA.0b013e3181a45d8619474692
  • Tan JW, Tan GHC, Ng WY, et al. High-grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Clin Oncol. 2020;25(5):984–994. doi:10.1007/s10147-019-01609-531915944
  • Narasimhan V, Tan S, Kong J, et al. Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis.Colorectal Dis. 2020;22(11):1482–1495.
  • van Eeghen EE, den Boer FC, Loffeld RJ. Thirty days post-operative mortality after surgery for colorectal cancer: a descriptive study. J Gastrointest Oncol. 2015;6(6):613–617. doi:10.3978/j.issn.2078-6891.2015.07926697192
  • Arnarson Ö, Butt-Tuna S, Syk I. Postoperative complications following colonic resection for cancer are associated with impaired long-term survival. Colorectal Dis. 2019;21(7):805–815. doi:10.1111/codi.1461330884061
  • Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359–374.8849962
  • Elias D, Blot F, El Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer. 2001;92(1):71–76. doi:10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO;2-911443611
  • Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29–42. doi:10.1097/00000658-199501000-000047826158
  • Koh JL, Yan TD, Glenn D, et al. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2009;16(2):327–333. doi:10.1245/s10434-008-0234-219050972
  • Hamashige S, Arquilla ER. Common terminology criteria for adverse events v3.0 (CTCAE). Principles Pract Clin Trial Med. 2008;42(4):461–533.
  • Wong EYT, Tan GHC, Chia CSL, et al. Morbidity and mortality of elderly patients following cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Asia Pac J Clin Oncol. 2018;14(2):e193–e202. doi:10.1111/ajco.1272328695617
  • Beckert S, Struller F, Horvath P, et al. Overall morbidity but not mortality is increased in elderly patients following cytoreductive surgery and HIPEC. Langenbecks Arch Surg. 2015;400(6):693–698. doi:10.1007/s00423-015-1325-826245705
  • López-López V, Cascales-Campos PA, Schneider MA, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in elderly patients. Syst Literature Rev Surg Oncol. 2016;25(4):378–384.